TheEdgeResearch
Home / Stocks / BIO.AX

Biome Australia Limited (BIO.AX)

ASX Healthcare Biotechnology
$0.30 ▲ +5.26%
Market Cap
$68.4M
Sector
Healthcare
Industry
Biotechnology
Beta
0.97
52-Wk Range
0.2-0.57
CEO
Blair William Brabin Vega Norfolk
Country
AU
Currency
AUD

Biome Australia Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Collingwood, VIC, AU. The stock last traded at $0.30, up 5.26% on the session, giving a market capitalisation of $68.4M. Its beta of 0.97 implies it has historically moved less than the broad market.

Company profile
Exchange
Australian Securities Exchange
Employees
30
IPO date
2021-11-29
Headquarters
Collingwood, VIC, AU
About Biome Australia Limited

Biome Australia Limited, founded in 2018 and headquartered in Cremorne, Australia, specializes in the development, commercialization, and global distribution of live biotherapeutic and complementary health products. The company's product line features live biotherapeutics under the Activated Probiotics brand, organic nutritional supplements branded as Activated Nutrients, and athletic performance and recovery items named Activated X Performance. These offerings are accessible to consumers through both community pharmacies and independent health practitioners.

Comparable companies

Biome Australia Limited is most often compared with the following Healthcare names:

ACW.AXALA.AXATH.AXATX.AXCYP.AXEZZ.AXILA.AXIMU.AXPCK.AXRCE.AX
More research on BIO.AX
BIO.AX technical analysis BIO.AX TheEdge Score Compare against peers
Open full interactive analysis & DCF →